MW Canopy Growth's mixed results stop momentum from recent marijuana-stock rally
By Steve Gelsi
Canadian pot company posts another quarterly loss as adult-use sales slump, despite some bright spots
Canopy Growth Corp.'s stock fell sharply in premarket trading as the Canadian pot company's wider-than-expected third-quarter loss chilled a recent rally in its share price.
While Canopy Growth $(CGC.AU)$ managed to reduce its losses and pay down debt, its operating margins fell as it invested in a new product launch. It also faced weaker adult-use sales, although its medical-pot business grew.
Canopy Growth's stock fell 15% in premarket trading, after rising nearly 40% in the past week.
Canopy Growth said its third-quarter loss narrowed to C$121.9 million ($85 million), or C$1.11 a share, from a loss of C$216.8 million or C$2.62 a share, in the year-ago period.
Analysts had expected Canopy Growth to post a narrower loss of 52 cents a share.
Revenue fell 5% to C$74.76 million, ahead of the FactSet consensus estimate of C$69.1 million.
Adult-use sales fell 10% to C$21.2 million, while medical-cannabis sales jumped 16% to C$19.6 million.
Third-quarter gross margin fell by 4% to 32% from the year-ago level. Canopy Growth cited incremental costs related to the launch of its Claybourne-infused pre-rolls, as well as higher indirect costs at its Storz & Bickel vaporizer unit.
Canopy Growth also reduced its third-quarter debt to C$442 million from the previous quarter's debt of $C554 million by making an early prepayment on its senior secured term loan.
Fresh speculation about U.S. federal reforms for pot, as well as a rally in fellow Canadian pot company Aurora Cannabis Inc. $(ACB)$ (CA:ACB) fed gains in cannabis stocks earlier this week
Also read: Cannabis stocks extend gains on RFK Jr. committee vote, Senate banking comments
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 07, 2025 08:15 ET (13:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。